AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: ENBREL (Amgen) (enbrel.com)
A rare example of ‘Regulatory Substance’ where legal mandates to disclose side effects inadvertently kill the marketing bullshit. While the technical SEO (Schema) is non-existent, the site provides a clinical level of detail that makes it difficult to dismiss as mere fluff. It is less a marketing site and more a legally-required safety manual with a ‘Simulator’ attachment.
Implement comprehensive Drug and Organization JSON-LD schema to bridge the technical authority gap. Replace generic ‘Images are for demonstration purposes only’ in the simulator with a link to the specific peer-reviewed study that validated the simulator’s model. Add direct outbound links to the FDA’s drug approval database for each specific indication. Reduce the BS score by moving the repetitive ISI block into a sticky modal or distinct footer to improve the signal-to-noise ratio of page-specific content.
The information density is exceptionally high due to regulatory requirements, though marketing headings like THINKING ABOUT ENBREL? and Watch how joint damage may progress over time.* lean toward fluff. Substance is found in the body text which details specific risks like tuberculosis (TB) and tumor necrosis factor (TNF) blockers. The specificity of the Indications section, which mentions age-specific approvals (children 2 years of age or older), provides high substance-to-fluff ratios in technical passages. However, the site suffers from extreme concept repetition, with the same 1,000+ word safety block appearing on every single page.
Black hole nodes and terminal leaf pages distort your hierarchy and weaken retrieval. Run a full Internal Linking Architecture analysis to expose the structural gaps hidden inside your graph.
There is virtually zero semantic drift between the homepage signal and the sub-page substance. The homepage meta description promises a treatment for autoimmune diseases, and the sub-pages for Rheumatoid Arthritis and Psoriatic Arthritis deliver precisely that with Joint Damage Simulators and Doctor Discussion Guides. The support page follows through on the homepage’s financial promise of Pay as little as $0* by providing the actual enrollment steps for the Co-Pay Program. Hierarchy is clear, and user intent is respected across the navigation path.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
The site displays a trust_theatre_flag because it registers review counts (1 on homepage, 2 on sub-pages) without providing direct outbound proof links to a third-party review aggregator. While it makes bold claims like stop permanent joint damage, these are contextualized by an asterisk leading to Prescribing Information rather than external clinical trial databases like ClinicalTrials.gov. The reliance on internal PDFs for proof rather than external validation links creates a slight trust theatre effect, despite being standard for the industry.
Proof density is moderate; while the site lacks outbound links to external peer-reviewed studies (proof_links_count: 0), it provides high-density internal proof via the Prescribing Information and Medication Guide references. Verifiable evidence includes specific FDA-approved indications for pJIA and PsO with exact age cutoffs (2 and 4 years old). Vague assertions are minimal because every claim is tethered to a safety warning or a clinical indication statement.
For a high volume editorial domain example, open the Search Engine Journal Semantic HTML audit. View the SEJ Semantic HTML Audit to see how template drift and structural noise impact AI chunking.
Boilerplate saturation is high because the Important Safety Information (ISI) occupies more than 50% of the text area on every page, acting as a massive template block. The value proposition of the Joint Damage Simulator is relatively unique but the generic call to action Get the Doctor Discussion Guide is a common industry template fingerprint. Industry clichés like #1 How is RA making you feel overall? follow standard patient-centric pharma marketing templates that could be applied to any competitor biologic.
The site has a significant technical authority gap as all schema_json fields are null, failing to use structured data to define the drug, the manufacturer (Amgen), or its FDA-approved status. While the content mentions the FDA and healthcare providers, there is no digital footprint linking to specific medical experts or research leads via Person schema. The technical implementation is functional but lacks the sophisticated authority signals (sameAs links, Drug schema) expected for a high-stakes pharmaceutical brand in 2026.
The site makes aggressive performance claims such as stop permanent joint damage and significantly relieve joint pain, which are essentially marketing translations of clinical endpoints. These claims are disconnected from raw data on the pages, as the site uses a Simulator for demonstration purposes only rather than showing actual patient outcome data or peer-reviewed study citations in the body text. The disclaimer that Progression of joint damage is unique for each individual patient serves as a legal buffer for these performance assertions.
Medical Devices, Pharma & Biotech BS: ENBREL (Amgen) (enbrel.com)
The site is an exact match for the Pharma and Biotech industry. The content is dominated by regulatory-mandated safety disclosures, clinical indications, and pharmacovigilance instructions, which are hallmarks of a Class III pharmaceutical product site.
AI does not interpret your layout visually — it interprets your structure mathematically. Explore the Semantic HTML Technical Framework to understand how heading logic, boundaries, and DOM depth determine what an LLM can retrieve.
“The score of 33 is driven by the total lack of structured data (Identity & Authority) and the extreme repetition of template safety text (Commodity Fingerprint). However, the site avoids a higher score due to its absolute lack of semantic drift and high density of technical medical information required for FDA compliance.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 30, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at ENBREL (Amgen) to view the most current version of their content and see directly what the company offers.